Supplement users may have better cancer survival: Study
Lung cancer patients who were regular dietary supplement users prior to diagnosis may have better survival chances than non-users, says a new study from Norway.
Archives for July 30, 2009
Omega-3 milk maker turns record H1 profits
Spanish food company, Ebro Puleva, has bucked the recession by registering a record first half result, with net profits surging 25 per cent to €98 million on turnover of €1.12 billion.
Study questions pomegranate supplement standardization
Standardizing pomegranate extract supplements to ellagic acid alone could be inaccurately representing their antioxidant activity and misleading consumers as to their health benefits, according to a study of commercially available products.
Green tea may protect against blood cell cancer
Drinking five or more cups of green tea per day may reduce the risk of blood- and lymph-based cancers by about 50 per cent, says a new study from Japan.
Fluxome readies for US and PUFA expansion
Danish biotech start-up, Fluxome, has moved to new premises in Copenhagen as it prepares to move into the poly unsaturated fatty acids (PUFA) market in 2010 and expand into the US.
FDA faces legal challenge over selenium health claims
A court action has been lodged today which challenges the Food and Drug Administration (FDA) qualified health claims system via five disputed selenium health claims.
House passes landmark food safety bill
The US House of Representatives passed a food safety bill on Thursday that promises far-reaching reform of how food is processed and grown, intended to boost food safety and consumer confidence.
New blend makes antioxidant rich chocolate easier to create, says Wild
Wild has launched a blend of plant extracts to help chocolate manufacturers create antioxidant rich products without needing to buy special quality cocoa beans.
MHRA reappoints botanicals and medicine chairs
The Medicines and Healthcare products Regulatory Agency (MHRA) has reappointed its Herbal Medicines Advisory Committee (HMAC) and Commission on Human Medicines (CHM) chairs.